DeepMed Research

Yonsei University

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: Private

Established: 1885-01-01

Employees: 5K

Market Cap: -

Website: http://www.yonsei.ac.kr

Clinical Trials

Effect of Raloxifene Plus Cholecalciferol and Cholecalciferol Alone on the Bone Mineral Density in Postmenopausal Women With Osteopenia

Phase 4

Completed

Conditions: Postemenopusal Women With Osteopenia

Interventions: Drug: Raloxifene plus cholecalciferol
Drug: Cholecalciferol

First Posted Date: 2022-05-23

Last Posted Date: 2024-04-17

Lead Sponsor: Yonsei University

Target Recruit Count: 112

Registration Number: NCT05386784

Locations: 🇰🇷
Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of

Association Between Erythroferron and Perioperative Hemoglobin Levels in Patient Undergoing Heart Valve Surgery

Conditions: Postoperative Anemia

First Posted Date: 2022-05-20

Last Posted Date: 2022-05-20

Lead Sponsor: Yonsei University

Target Recruit Count: 150

Registration Number: NCT05384054

Locations: 🇰🇷
Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of

The Ultrasonographic Measurement of Quadriceps Muscle Thickness and the Shape of the Femoral Nerve in Patients Undergoing Total Knee Arthroplasty: an Observational Study

Conditions: Total Knee Arthroplasty

First Posted Date: 2022-05-19

Last Posted Date: 2022-05-27

Lead Sponsor: Yonsei University

Target Recruit Count: 200

Registration Number: NCT05382507

Locations: 🇰🇷
Yonsei University Health System, Severance Hospital, Seoul, Seodaemun-gu, Korea, Republic of

Effect of Pressure Support Ventilation During Anesthetic Emergence on Postoperative Atelectasis in Infant

Not Applicable

Conditions: Infants Aged 0 Days to 13 Months Scheduled for Elective Surgery

Interventions: Other: pressure support, group PS
Other: conventional ventilation, group C

First Posted Date: 2022-05-13

Last Posted Date: 2022-05-13

Lead Sponsor: Yonsei University

Target Recruit Count: 136

Registration Number: NCT05373589

Locations: 🇰🇷
Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of

A Window of Opportunity Study for Investigating Drug Tolerant Persister (DTP) to Preoperative Brigatinib in Resectable Non-small Cell Lung Cancer (NSCLC) Harboring ALK Fusions.

Phase 2

Conditions: Non-small Cell Lung Cancer

Interventions: Drug: Brigatinib

First Posted Date: 2022-05-04

Last Posted Date: 2022-05-04

Lead Sponsor: Yonsei University

Target Recruit Count: 12

Registration Number: NCT05361564

Locations: 🇰🇷
Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of

Effect of Intensive LDL-cholesterol Targeting for Elderly Patients With Cardiovascular Disease: I-OLD Trial

Phase 4

Recruiting

Conditions: Cardiovascular Disease

Interventions: Drug: Conventional therapy group
Drug: Intensive targeting group

First Posted Date: 2022-05-04

Last Posted Date: 2024-03-15

Lead Sponsor: Yonsei University

Target Recruit Count: 1200

Registration Number: NCT05361421

Locations: 🇰🇷
Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of

A Clinical Trial to Evaluate Efficacy of Once or Twice ZOledronic Acid After Different Duration of denOsumMab Administration in Postmenopausal Women With Osteoporosis (ZOOM Study)

Phase 4

Completed

Conditions: Osteoporosis

Interventions: Drug: Zoledronic acid, once
Drug: Zoledronic acid, twice

First Posted Date: 2022-05-04

Last Posted Date: 2025-03-07

Lead Sponsor: Yonsei University

Target Recruit Count: 114

Registration Number: NCT05361408

Locations: 🇰🇷
Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of

Low Dose Prasugrel vs Clopidogrel for Stenting or Flow Diverter for Unruptured Aneurysm

Phase 4

Recruiting

Conditions: Intracranial Aneurysm

Interventions: Drug: Clopidogrel group
Drug: Prasugrel group

First Posted Date: 2022-05-03

Last Posted Date: 2022-07-15

Lead Sponsor: Yonsei University

Target Recruit Count: 406

Registration Number: NCT05359224

Locations: 🇰🇷
Yongin Severance hospital, Yonsei university college of medicine, Gyeonggi-do, Yongin-si, Korea, Republic of

A Clinical Trial to Evaluate the Detection of Atrial Fibrillation for an One Day Versus More Than or Equal to Eight Days Using MEMO Patch PLUS in Individuals Aged ≥ 75 Years, or Those at High Risk of Stroke

Not Applicable

Conditions: Atrial Fibrillation/Flutter in Patients With High Risk of Stroke

Interventions: Device: MEMO Patch PLUS for More than 8-days
Device: MEMO Patch PLUS for 1 day

First Posted Date: 2022-05-02

Last Posted Date: 2022-05-02

Lead Sponsor: Yonsei University

Target Recruit Count: 1000

Registration Number: NCT05355948

Locations: 🇰🇷
Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of

Efficacy and Safety of Zotarolimus-eluting Stent Overexpansion With OCT

Recruiting

Conditions: Coronary Artery Disease
Optical Coherence Tomography
Stent

Interventions: Device: Optical coherence tomography-guided percutaneous coronary intervention
Device: Optical coherence tomography-guided Onyx family stent expansion

First Posted Date: 2022-04-22

Last Posted Date: 2024-06-03

Lead Sponsor: Yonsei University

Target Recruit Count: 30

Registration Number: NCT05340361

Locations: 🇰🇷
Yongin Severance Hospital, Yongin, Gyeonggi-do, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy